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Abstract  51 
Endometriosis occurs in approximately 10% of women and is associated with 52 
persistent pelvic pain. It is defined by the presence of endometrial tissue (lesions) outside the 53 
uterus, most commonly on the peritoneum. Peripheral neuroinflammation, a process 54 
characterised by the infiltration of nerve fibres and macrophages into lesions, is believed to 55 
play a pivotal role in endometriosis-associated pain. The objective was to determine the role 56 
of estradiol in regulating the interaction between macrophages and nerves in peritoneal 57 
endometriosis. Using human tissues and a mouse model of endometriosis, we demonstrate 58 
that macrophages in lesions recovered from women and mice are immuno-positive for 59 
estrogen receptor beta, with up to 20% being estrogen receptor alpha positive. In mice, 60 
treatment with estradiol increased the number of macrophages in lesions as well as 61 
concentrations of mRNAs encoded by Csf-1, Nt-3 and the tyrosine kinase neurotrophin 62 
receptor TrkB. Using in vitro models we determined that treatment of rat dorsal root ganglia 63 
neurons with estradiol increased mRNA concentrations of the chemokine Ccl-2 that 64 
stimulated migration of CSF-1 differentiated macrophages. Conversely, incubation of CSF-1 65 
macrophages with estradiol increased concentrations of brain-derived neurotrophic factor 66 
(BDNF) and neurotrophin 3 (NT-3) that stimulated neurite outgrowth from ganglia explants. 67 
In summary, we have demonstrated a key role for estradiol in stimulating macrophage-nerve 68 
interactions providing novel evidence that endometriosis is an estrogen-dependent 69 
neuroinflammatory disorder. 70 
 71 
 72 
 73 
 74 
 75 
4 
 
Introduction 76 
 Endometriosis affects 10% of reproductive age women and is associated with 77 
persistent pelvic pain 1. It is defined by the presence of endometrial-like tissue (lesions) found 78 
outside the uterus, most commonly on the peritoneum. The mechanisms underlying 79 
endometriosis-associated pain are poorly understood but it has been postulated that estrogen-80 
dependent neuroinflammation may be involved 2. Notably the presence of endometrial tissue 81 
fragments on the peritoneum elicits an immune response, including recruitment of 82 
macrophages 3, blood vessels and nerve fibres into the resultant lesions 4, 5. Within the lesions 83 
CD68+ macrophages have been detected in close association with nerve fibres 6.  84 
Studies investigating macrophage activation and recruitment have revealed that 85 
endometriosis-associated macrophages exhibit a phenotype consistent with the ‘alternative’ 86 
end of the macrophage activation spectrum 7, 8. In a mouse model of endometriosis that 87 
included cell transfer of polarised macrophages, Bacci et al reported that mice injected with 88 
pro-inflammatory macrophages (M(IFNγ)) developed microscopic lesions but those injected 89 
with alternatively activated macrophages (M(IL-4)) developed larger lesions with a well-90 
developed vasculature 7. Our studies in a mouse model of endometriosis have revealed that 91 
macrophages resident in peritoneal lesions can originate from both the peritoneum and the 92 
endometrium 9. 93 
 Sensory C, sensory Aδ, cholinergic and adrenergic nerve fibres have been identified 94 
within lesions 10, 11 with greater nerve fibre density in areas that exhibit high macrophage 95 
density 6. Studies in zebrafish have shown that macrophages will migrate towards damaged 96 
peripheral nerves 12 consistent with a role for neuron-derived factors in immune-nerve cross-97 
talk.  98 
 Endometriosis lesions have an estrogen-rich microenvironment associated with 99 
enhanced expression of biosynthetic enzymes including aromatase 13. It is well established 100 
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that estrogen action can be mediated by estrogen receptors alpha (ERα) and beta (ERβ), both 101 
are widely expressed in the human endometrium 14. Notably a proportion of the soma of 102 
afferent nerve fibres innervating the uterus and peritoneum are reported to express one or 103 
both ERs 15. Although some studies have analysed the expression of ERs in macrophages 104 
isolated from the peritoneal fluid of women with endometriosis 16, 17 expression of ERs in 105 
lesion resident macrophages has not yet been determined. 106 
 The objective of our study was to determine whether estradiol might play a role in the 107 
regulation of macrophage-nerve crosstalk in endometriosis both by exploring the expression 108 
of ERs in human tissue samples as well as the impact of estradiol (E2) on nerves and 109 
macrophages using in vitro and in vivo models. 110 
 111 
Material and methods 112 
Human tissues  113 
Eutopic endometrium (n=5) and peritoneal endometriosis lesions (n=10) from patients 114 
with endometriosis were collected during laparoscopy (mean age ± SD: 35.1 ± 6.08; range: 115 
26-45 years). Fixed sections of endometriosis lesions were evaluated following staining with 116 
H&E and only those that contained both glandular and stromal compartments were used for 117 
this study. Dating of eutopic endometrial histology 18 and serum hormone measurements 118 
were used to confirm menstrual cycle phase. Endometriosis stage was provided during 119 
surgery using the revised American Society of Reproductive Medicine classification 120 
(rASRM; I=60%, II= 20%, III=20%). Endometrium (n=5) and peritoneal biopsies (n=8) from 121 
women without evidence of clinical endometriosis were also collected during laparoscopy. 122 
All patients had regular cycles and had not taken hormones at least 3 months prior to surgery. 123 
The study was approved by the Lothian Research Ethics Committee (LREC 11/AL/0376) and 124 
the Ethics Committee of Charité – Universitätsmedizin Berlin (EA4/023/05). All patients 125 
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provided written, informed consent. Samples were fixed in 4% neutral buffered formalin 126 
(NBF) or stored in RNAlater (Applied Biosystems, Warrington, UK).  127 
Mouse model of endometriosis 128 
Endometriosis was induced using wild type and transgenic Cfs1r-EGFP mice 129 
(MacGreen) 19 on a C57BL/6 background using a previously validated model of 130 
endometriosis as described 9. In brief, donor endometrial tissue was recovered during induced 131 
‘menses’ 20 and injected into the peritoneal cavity of recipient mice. Lesions (EL) and 132 
peritoneum (EP) were collected from endometriosis mice (n=8) 21days after inoculation of 133 
the peritoneum. In an additional group of mice, on day 21 the 17β-estradiol (E2) 134 
subcutaneous pellet was either removed (no hormone control; n =5) or retained (E2 135 
treatment; n= 8, mice randomly assigned to groups). After a further 7 days (day 28 of the 136 
protocol), mice were culled, lesions and peritoneum removed and either stored in RNAlater 137 
or fixed in NBF and processed so that the presence of glands and stroma could be confirmed. 138 
Control tissues (uterus, peritoneum) were recovered from naïve control mice (n=6). 139 
Cell culture and estradiol treatments 140 
Dorsal root ganglia (DRG) isolation 141 
Rat DRGs were isolated as previously described 21. Dissociated DRGs were used for 142 
RNA extraction and qRT-PCR. At least 24 hours prior to experiments, the medium was 143 
changed to phenol red free media, fetal calf serum (FCS) was stripped with activated charcoal 144 
then added to the media at a concentration of 1%. Cells were stimulated with vehicle control 145 
(dimethyl sulfoxide (DMSO)), E2 at a final concentration of 10-8M (Sigma, UK), alone or in 146 
combination with the anti-estrogen Fulvestrant (ICI 182780, final concentration 10-7M; 147 
Tocris, UK). E2 and ICI were dissolved in DMSO to yield stock solutions of 10-2M, all cells 148 
were exposed to a final DMSO concentration of 1:1 x 104 dilution. DRG-conditioned media 149 
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was collected, centrifuged and stored at -80°C and used for the macrophage migration assay.  150 
All experiments were performed in triplicates.  151 
Human peripheral blood monocyte isolation and macrophage differentiation 152 
Human venous blood was collected from healthy female volunteers (n=5) with 153 
informed consent (LREC 08/S1103/38). To isolate mononuclear leukocytes, blood was 154 
centrifuged (350g, 20min) and platelet-rich plasma (PRP) aspirated. Erythrocytes were 155 
sedimented with 0.6% (w/v) dextran followed by separation of leukocytes using a Percoll™ 156 
(GE Healthcare, UK) gradient and centrifugation at 720g for 20min. Mononuclear leukocytes 157 
were aspirated and monocytes isolated by negative selection using a monocyte isolation kit II 158 
(Miltenyi Biotech, Surrey, UK). Adherent monocytes were cultured in the presence of 159 
colony-stimulating factor 1 (CSF-1; 4ng/ml) to generate monocyte-derived macrophages 160 
hereby referred to as M(CSF-1) in accordance with the recently published macrophage 161 
nomenclature guidelines 22, for 4 days in Iscove’s DMEM (IMDM, Life Technologies, 162 
Paisley, UK) containing 10% autologous serum, prepared by re-calcification of PRP (12 well 163 
plates, 37 °C in 5% CO2). M(CSF-1) were exposed to DMSO (M(CSF-1+DMSO), 10-8M E2 164 
(M(CSF-1+E2)) or 10-8M E2 plus 10-7M ICI (M(CSF-1+E2+ICI)) for 24h at 37 °C at 5% 165 
CO2 on day 5. Macrophage conditioned media was collected, centrifuged and stored at -80°C 166 
until further use for the neurite outgrowth assays. All experiments were performed in 167 
triplicates. 168 
RNA extraction and cDNA synthesis  169 
RNA was extracted from DRGs and macrophages using the RNAeasy mini kit 170 
(Qiagen, Sussex, UK), concentration and purity was analysed using a Nanodrop (LabTech 171 
International, Sussex, UK). cDNA was synthesized using SuperScript® VILO™ (Invitrogen, 172 
Paisley, UK) with a starting template of 100ng/µl.  173 
 174 
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Quantitative real time PCR 175 
Real-time PCR reactions were performed using the Roche Universal ProbeLibrary 176 
(Roche Applied Science, West Sussex, UK) and Express qPCR Supermix (Invitrogen) in a 177 
7900 Fast Real-Time PCR with 18S as the endogenous control. Primer sequences (Eurofins 178 
MWG operon, Germany) are listed in Table 1. Expression of target genes was related to 179 
expression of 18S ribosomal RNA and to an internal control sample using the 2−ΔΔCt 180 
method.  181 
Functional assays 182 
Neurite outgrowth assay 183 
Single whole DRG explants from E15.5 rat embryos were incubated with DMEM 184 
plus 0.1ng/ml NGF (positive control), IMDM plus autologous serum (negative control) or 185 
conditioned medium (CM) from macrophages treated for 24 h with DMSO, E2 or E2+ICI 186 
(n=5 female volunteers) for 24h and 48h at 37°C with 5% CO2 in Poly-D-lysine and Matrigel 187 
(BD Biosciences, UK) coated 12 well plates. Neurite outgrowth was analysed as previously 188 
described 21. Neutralisation experiments were performed using anti-BDNF (0.4µg/ml) and 189 
anti-NT-3 (0.2µg/ml; R & D systems, Oxford, UK). CM was pre-incubated with neutralising 190 
antibodies for 1 hour before experiments were performed. The treatments were performed in 191 
duplicate for each of the 5 patients and each duplicate used to incubate 3 DRGs. 192 
Macrophage migration assay 193 
The macrophage migration assay was performed using µ-Slide V1.04 migration slides 194 
(Ibidi®, Munich, Germany). CM (80µl) from DRG exposed to DMSO, E2 or E2+ICI (see 195 
previous) was aliquoted into one chamber and macrophages (5 X 104 cells) were aliquoted 196 
into the other chamber and slides incubated for 16h then evaluated using an Axiovert 197 
microscope (Carl Zeiss, Germany). A migration score was allocated to each slide based on 198 
the distance migrated and the % of macrophages mobilised towards the chamber containing 199 
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the DRG media. Neutralisation experiments were performed using an anti-CCL-2 antibody 200 
(0.5µg/ml; BioLegend, CA, USA) and an anti-CCL-3 antibody (0.45µg/ml; R and D 201 
systems). CM was pre-incubated with neutralising antibodies for 1 hour before experiments 202 
were performed. DRG treatments were performed in triplicate in 4 separate experiments and 203 
used in migration experiments from 4 macrophage preparations (4 female volunteers). 204 
Immunodetection 205 
Dual immunofluorescence  206 
Dual immunofluorescence was carried out as previously described 21. In brief, 207 
sections were antigen retrieved, blocked for endogenous peroxidase and non-specific epitopes 208 
and incubated with primary antibody at 4°C overnight (Table 2). Antibody detection was 209 
performed using a secondary F(ab) polyclonal antibody to IgG (HRP) and TSA system kit 210 
labelled with Cy3 (red) or fluorescein (green; 1:50 dilution, Perkin Elmer Inc, MA, USA). 211 
For detection of the second antigen sections were microwaved in boiling citrate buffer, the 212 
second primary antibody applied overnight at 4ºC, and detection as above. The sections were 213 
counterstained with DAPI, mounted in Permafluor (Thermo Fisher Scientific, Loughborough, 214 
UK) and imaged using a LSM710 confocal microscope and AxioCam camera (Carl Zeiss Inc, 215 
UK). Human or mouse uterus was used as a positive control tissue and negative controls had 216 
omission of the primary antibody. Macrophage number in lesion and peritoneal sections was 217 
quantified by randomly capturing 4 (human) or 3 (mouse) fields of view (FOV) associated 218 
with glandular and stromal tissue in endometriosis lesions. A mean was generated and plotted 219 
for each biological sample 21. 220 
Immunofluorescence on cultured cells 221 
Cultured DRGs were stained using a NF H chicken anti-neurofilament H antibody 222 
(1:1000, Covance, UK) to visualise neurite projections. Cultured macrophages were fixed for 223 
20 mins using ice cold methanol, permeabilised using Triton-X, blocked with Avidin/Biotin 224 
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(Vector), and species specific blocking buffer for non-specific epitopes. Macrophages were 225 
incubated with primary antibody (CD68, ERα or ERβ) overnight at 4°C. Antibody binding 226 
was detected using a biotinylated secondary antibody followed by streptavidin alexafluor 555 227 
and counterstained with DAPI. Images were captured using an Axiovert microscope (Carl 228 
Zeiss), Axiovision camera and software. 229 
Statistical analysis 230 
The data were expressed as means ± SEM and were analysed using a one-way ANOVA and 231 
Newman Keuls multiple comparison test or a Students T test for two group comparisons. 232 
Analysis of QPCR data was performed on transformed values. *:p<0.05, **:p<0.01, 233 
***:p<0.001. Analyses were carried out using GraphPad Prism 6 software.  234 
 235 
Results 236 
Macrophages and nerve fibres are found in close association in peritoneal endometriosis 237 
lesions 238 
In peritoneal lesions from women with endometriosis, macrophages (immuno-positive 239 
for CD68, red) were identified in close association with small diameter nerve fibres, typical 240 
of afferent sensory innervation (immunopositive for PGP9.5; green; Fig.1A-B). Clustering of 241 
CD68+ macrophages around nerve bundle structures was consistently observed in tissue 242 
close to glandular epithelium in peritoneal lesions (Fig.S1). In lesions recovered from 243 
transgenic Cfs1r-EGFP (MacGreen) mice, GFP+ macrophages were also detected close to 244 
nerve fibres (Fig.1C-D; GFP; red, PGP9.5; green). 245 
Estrogen receptor beta (ERβ) is the predominant estrogen receptor expressed by lesion 246 
resident macrophages 247 
Significantly higher numbers of CD68+ macrophages were detected in sections of 248 
peritoneal endometriosis lesions compared to sections of unaffected peritoneum (p<0.001; 249 
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Fig.1E). In women, CD68+ macrophages resident in the eutopic endometrium were immuno-250 
negative for ERα (Fig.S2A; CD68; red, ERα; green) but immuno-positive for ERβ (Fig.S2B, 251 
ERβ; green) regardless of whether they had been diagnosed with endometriosis (Fig.S2C-D). 252 
In peritoneal biopsies from women without endometriosis ERα was immuno-localised to 253 
approximately a tenth of CD68+ macrophages (10.6% ± 3.85) (Fig.1F, Fig.S2E) but all the 254 
macrophages were ERβ positive (Fig.S2F). In peritoneal endometriosis lesions approximately 255 
a fifth of the CD68+ macrophages (18.3% ± 4.37) were immuno-positive for ERα (Fig.1G) 256 
and as in the normal peritoneum they were all immuno-positive for ERβ (Fig.1H). Results 257 
obtained in our mouse model of endometriosis mirrored those in women with significantly 258 
higher numbers of GFP+ macrophages in lesions (p<0.05) compared to the peritoneum of 259 
naïve mice (Fig.1I). A tenth of mouse peritoneal macrophages (10.14±6.41) and a quarter of 260 
lesion resident macrophages (24.82±5.57) were immuno-positive for ERα (Fig.1J-K) with all 261 
GFP+ cells being immuno-positive for ERβ (Fig.1L).  262 
Human peripheral blood monocytes were isolated and differentiated into macrophages 263 
that are classified as being at the alternative end of the macrophage activation spectrum 22 by 264 
incubating them in the presence of CSF-1 hereafter referred to as M(CSF-1). M(CSF-1) 265 
incubated with estradiol are referred to as M(CSF-1+E2). All isolated cells were confirmed as 266 
macrophages using CD68 immunocytochemistry (Fig.1M). M(CSF-1+E2) contained mRNAs 267 
encoding ERα and ERβ (Fig.S3A-B). Protein localisation revealed a mixed population of 268 
ERα positive and negative macrophages; ERα was detected in 66% of cells (Fig.1N) whereas 269 
ERβ was detected in all cells (Fig.1O).  270 
Nerve fibres recruit macrophages in an estradiol-dependent manner in vitro 271 
We explored the impact of products secreted by DRGs in response to stimulation with 272 
E2 on the migration of M(CSF-1) using an in vitro macrophage migration assay. Conditioned 273 
media (CM) from DRGs stimulated for 24h with DMSO, E2, or E2 plus the anti-estrogen ICI 274 
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was placed in one chamber and M(CSF-1) were placed in the other (Fig.2A). M(CSF-1) 275 
migrated furthest towards CM from DRG exposed to E2 (p<0.01), this effect was not 276 
observed using CM from DRG exposed to E2+ICI, indicating an ER specific effect (Fig.2B). 277 
Notably, addition of E2 to the medium in the absence of DRG had no effect on the migration 278 
of the macrophages (data not shown), verifying a role for E2-dependent DRG derived 279 
secretory products in enhancing macrophage migration. QPCR analysis of E2-treated DRGs 280 
revealed ER-dependent regulation of a macrophage growth factor and two chemokines. 281 
Specifically, mRNA concentrations of colony-stimulating factor 1 (Csf-1) were up-regulated 282 
by E2 (p<0.001; Fig.2C), as were chemokine (C-C motif) ligand 2 (Ccl2-2) and 3 (Ccl-3) 283 
mRNAs (p<0.05; Fig.2D and E). Addition of ICI abrogated the effect of E2. Addition of an 284 
anti-CCL-2 antibody to DRG CM abolished the E2 induced macrophage chemotactic 285 
properties (p<0.01) whereas addition of an anti-CCL-3 antibody attenuated E2 induced 286 
macrophage chemotactic properties of DRG CM (Fig.2F).  287 
Estradiol induces neurotrophic properties in macrophages 288 
DRGs were cultured in CM from M(CSF-1) and neurite outgrowth was recorded 289 
(Fig.3A). CM from E2 activated macrophages M(CSF-1+E2) significantly enhanced neurite 290 
outgrowth compared to CM from M(CSF-1+DMSO) or M(CSF-1+E2+ICI) at 24h and 48h  291 
(Fig.3B-D; p<0.001). Analysis of M(CSF-1) mRNAs revealed that neurotrophins were up-292 
regulated by E2 treatment. Specifically, mRNA concentrations of brain derived neurotrophic 293 
factor (BDNF) and neurotrophin 3 (NT-3) were significantly increased in M(CSF-1+E2) 294 
compared to M(CSF-1+DMSO) (p<0.001 and p<0.01 respectively; Fig.3E and F). This effect 295 
was abrogated by the addition of ICI confirming it was receptor-dependent. To verify a role 296 
for BDNF and NT-3 in the neurotrophic properties of M(CSF-1+E2), single whole DRG 297 
were incubated with CM from M(CSF-1) (Fig.3A) in combination with neutralising 298 
antibodies targeted to BDNF or NT-3. The neurotrophic properties of CM from M(CSF-299 
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1+E2) were abolished by anti-BDNF or anti-NT-3 (p<0.01; Fig.3G and H). This effect was 300 
not observed when the neutralising antibodies were added to DRG cultured in neuronal media 301 
in the presence of NGF.  302 
Macrophage infiltration of endometriosis lesions is estradiol-dependent in a mouse 303 
model of endometriosis 304 
Lesions recovered from mice exposed to E2 contained significantly more GFP+ cells 305 
than mice that had hormonal support withdrawn (p<0.05; Fig.4A-C). We have previously 306 
reported that Ccl-2 and Ccl-5 (Rantes) mRNA concentrations were elevated in mouse 307 
endometriosis lesions 9 and herein we show that mRNA concentrations of the chemokine Ccl-308 
3 were also significantly elevated in mouse endometriosis lesions (p<0.01) compared to 309 
biopsies of naïve uterus and peritoneum (Fig.4D). 310 
Csf-1, Nt-3 and TrkB are estradiol-regulated in a mouse model of endometriosis 311 
Csf-1 and Nt-3 mRNA concentrations were significantly higher in lesions than other 312 
tissue samples (Fig.5A-B). mRNA concentrations of the tyrosine kinase receptor that binds 313 
both Bdnf and Nt-3 (TrkB) was also up-regulated in lesions (Fig.5C). Concentrations of 314 
mRNAs encoded by Csf-1, Nt-3 and TrkB were significantly higher in the lesions exposed to 315 
E2 compared to those recovered from mice in which E2 was withdrawn after lesions were 316 
established (Fig.5D-F).  317 
 318 
Discussion 319 
 Endometriosis is a steroid-dependent disorder; lesions exhibit the capacity for 320 
enhanced tissue biosynthesis of estrogens as well as alterations in estrogen receptor protein 321 
expression 21, 23. In the current study, we provide new evidence that estrogens play a key role 322 
in the regulation of interactions between macrophages and nerve fibres in endometriosis. 323 
Specifically, using in vitro model systems we found that DRG neurons produced chemokines 324 
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in response to E2 that promoted macrophage recruitment, whilst macrophages stimulated 325 
with E2 produced neurotrophins that promoted neuronal outgrowths. Using a mouse model of 326 
endometriosis 9 we demonstrated that macrophage infiltration of endometriosis lesions was 327 
E2-dependent and that the concentrations of mRNAs encoding Csf-1, Nt-3 and TrkB were E2-328 
regulated in mouse lesions. 329 
 Estrogen can bind directly to either ERα or ERβ resulting in ligand dependent changes 330 
in receptor function and gene expression. We have previously demonstrated that endothelial 331 
cells within both normal endometrium 14, 24 and peritoneal lesions 21 are ERβ+/ERα-. Notably, 332 
E2 treatment of immortalised human endometrial endothelial cells resulted in changes in gene 333 
expression of the axonal guidance factor SLIT3 consistent with the suggestion that 334 
neuroangiogenesis can be modulated by estrogen. In this study we used fluorescent 335 
immunohistochemistry to explore the ER phenotype of macrophages within eutopic and 336 
ectopic endometrium in women and in our mouse model. Notably all CD68+ macrophages in 337 
peritoneum and lesions from women, and all GFP+ macrophages in the peritoneum and 338 
lesions from mice were immuno-positive for ERβ. In contrast peritoneal and lesion resident 339 
macrophages were a mixed population of ERα+ and ERα- cells. There was no clear evidence 340 
of either population residing in specific microenvironments, as ERα+ cells were often 341 
detected adjacent to ERα- cells.  As we have previously reported data from our mouse model 342 
of endometriosis showing lesion-resident GFP+ macrophages may originate from both the 343 
peritoneum and the ‘shed’ endometrium 9 we wondered if the heterogeneous expression of 344 
ERα might be a reflection of different origins (endometrial macrophages are all ERα-) but 345 
since there was no significant difference in proportions of ERα+ cells in lesions and 346 
peritoneum this cannot be the case. It therefore remains to be determined what regulates the 347 
amount of ERα protein in CD68+ macrophages. One plausible explanation being that the 348 
ERα cells have infiltrated from peripheral blood (ERα is expressed by peripheral blood 349 
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monocyte-derived macrophages). Macrophages isolated from the peritoneal fluid of women 350 
with endometriosis are reported to be immuno-positive for both ERα and ERβ, and that ER 351 
immunolocalisation is increased in women with endometriosis compared to women without 352 
endometriosis16, 25. ER expression in lesion-resident macrophages had not been examined 353 
until now. Our findings differed from the previous studies in that ERα was only detected in a 354 
subset of macrophages in both peritoneal (from women without endometriosis) and lesion 355 
biopsies, we also found no difference in ER immunolocalisation in macrophages from 356 
women with and without endometriosis.  We suggest that this discrepancy in findings is due 357 
to the inherent differences between peritoneal fluid macrophages (naïve and un-stimulated in 358 
disease free conditions)26 and tissue macrophages (activated).   Although the phenotype of 359 
macrophages present in the eutopic endometrium may alter throughout the menstrual cycle 27, 360 
recent reports suggest that they have a phenotype closer to the alternative (‘M2-like’) end of 361 
the macrophage activation spectrum 28, a similar phenotype has been reported for 362 
endometriosis-associated macrophages 7. We postulate that macrophages in the shed 363 
endometrium may retain their phenotype and the local ‘endometrial’ microenvironment of the 364 
ectopic endometrial tissue re-programmes the macrophages infiltrating the lesion from the 365 
peritoneum.  366 
 We and others documented the presence of macrophages and nerves in close 367 
association in tissue-sections from lesions 6. The nuclei of sensory neurons innervating the 368 
uterus are known to express estrogen receptors15, and ER-dependent signaling modulates a 369 
range of processes in peripheral nerves29, 30. We were therefore interested to explore whether 370 
the estrogen dominated microenvironment could play a role in modulating interactions 371 
between macrophages and nerves and what regulatory factors may be involved... Using a 372 
migration assay to determine whether neurons could release factors influencing macrophages 373 
we found evidence that addition of CM from DRGs treated with E2 enhanced macrophage 374 
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migration and that Ccl-2 and Ccl-3 mRNA concentrations in DRGs was ER-regulated. 375 
Importantly when an antibody directed against Ccl-2 was added to the CM macrophage 376 
migration was abrogated suggesting this was a key E2-dependent factor involved in neuron 377 
mediated macrophage migration. Notably elevated CCL-2 concentrations have been detected 378 
in peritoneal fluid of women with endometriosis 31. Moreover, Luk et al demonstrated that 379 
CCL-2 concentrations were increased by E2 in endometrial endothelial cells from women 380 
with endometriosis 32. Their study and ours both provide evidence that E2 modulates 381 
recruitment of macrophages via CCL-2 to endothelial cells and nerve fibres in endometriosis 382 
lesions. 383 
CSF-1 is a critical growth factor involved in macrophage survival, proliferation and 384 
differentiation 33. Csf-1 may play a critical role in early development of endometriosis 385 
lesions; mice homozygous for a Csf-1 mutation (Csf-1 op/op) developed significantly less 386 
lesions in a model of endometriosis compared to wild type controls 34. Elevated CSF-1 387 
concentrations have also been reported in the peritoneal fluid of women with endometriosis 388 
35. In our study, mRNA concentrations of Csf-1 were increased in lesions recovered from 389 
mice and were also increased in DRGs exposed to E2. Based on these results, we suggest that 390 
the ER-dependent regulation of CSF-1 in peripheral nerve fibres present in endometriosis 391 
lesions may play a role in modulating macrophage survival and phenotype, and is consistent 392 
with the hypothesis that neurogenic inflammation is a key process is this disorder.  393 
 E2 is reported to be neuroprotective 36; these effects have been linked to E2-394 
dependent expression of BDNF promoting neuron survival, regeneration and synaptogenesis 395 
37. NT-3 is elevated in the peritoneal fluid of women with endometriosis 38, but the cellular 396 
source is uncertain. In this study, E2 increased the neurotrophic properties of macrophages 397 
via up-regulation of BDNF and NT-3, suggesting that this cell type is a key source of these 398 
neurotrophins contributing to E2-dependent nerve growth into lesions. Notably, the mRNA 399 
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concentrations of Nt-3 and the neurotrophin receptor TrkB were also E2-regulated in the 400 
lesions induced in mice complementing the data from the in vitro models. 401 
It has been proposed that endometriosis-associated macrophages may identify the 402 
ectopic endometrial tissue as a ‘wound’ and activate pathways supporting cell survival and 403 
angiogenesis rather than phagocytosis of ectopic material 39. Macrophages are vital in the 404 
regeneration of damaged nerves following injury to the CNS and PNS and although 405 
infiltrating sensory nerves present within endometriosis lesions are not ‘damaged’ per se, 406 
they may experience a chemical milieu similar to inflammation in response to trauma 40. In a 407 
mouse model of acute peripheral nerve injury an alternative macrophage response was 408 
detected 41, and this phenotype has been associated with a sterile inflammatory environment 409 
similar to endometriosis. We suggest that the reciprocal relationship between macrophages 410 
and nerves encourages innervation of endometriosis lesions. Moreover, the close proximity of 411 
macrophages and nerves within lesions suggests that macrophage-derived cytokines may also 412 
contribute to pelvic pain in endometriosis by acting directly on nociceptors generating a pain 413 
response and hypersensitivity 40, 42. We have previously shown that estrogens can also act 414 
directly on human sensory neurons to increase the mRNA concentrations of key nociceptive 415 
ion channels including TAC1, P2RX3 and TRPV1 43, further supporting a role for estrogens in 416 
modulating pain response in endometriosis by acting on nerves.  417 
 Our data have led us to propose the following model; elevated levels of estrogens 418 
present within the lesion microenvironment act to mediate interactions between macrophages 419 
and nerve fibres whereby estrogen acts on nerve fibres to enhance the expression of CSF1 420 
and CCL-2, recruiting macrophages to nerve fibres. Reciprocally, estrogens act on 421 
macrophages to enhance expression of BDNF and NT-3 which further potentiates 422 
neurogenesis into lesions (Fig.6). In conclusion, these new results provide compelling 423 
evidence that estrogens produced by the ovaries, as well as within lesions, play a pivotal role 424 
18 
 
in cross-talk between neurons and macrophages which underpins development of pain 425 
symptoms in women with endometriosis. The identification of E2-dependent factors that 426 
regulate the process of macrophage-mediated nerve growth into lesions may offer novel 427 
targets for inhibition that may be preferred over medically induced hypo-estrogenism. 428 
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Figure legends 593 
Fig.1. Macrophages are found in close association with nerve fibres in endometriosis 594 
lesions and express estrogen receptors. (A-B) Macrophages are found in close proximity to 595 
small diameter nerve fibres in human peritoneal lesion biopsies. Dual immunofluorescence 596 
carried out using the macrophage marker CD68 (red) and the pan neuronal marker protein 597 
gene product 9.5 (PGP9.5; green). Nuclei stained with DAPI (blue). Scale bar = 20 and 598 
50µM, respectively. Inset in (B) is an enlarged image. (C-D) Macrophages are also found 599 
near small diameter nerve fibres in lesions recovered from a mouse model of endometriosis. 600 
To aid in the localisation of macrophages we used the MacGreen mouse; a transgenic mouse 601 
with eGFP labelled macrophages for our mouse model of endometriosis.  Dual 602 
immunofluorescence carried out using an anti-GFP antibody (red) PGP9.5 (green) on lesions 603 
recovered from mice. Nuclei stained with DAPI (blue). Scale bar = 50µM. (E) Significantly 604 
higher numbers of CD68+ macrophages were detected in peritoneal endometriosis lesions 605 
(n=10) compared to the healthy peritoneum (n=8). CD68+ cells were counted in 4 randomly 606 
selected fields of view (FOV) associated with glandular and stromal tissue in lesions and the 607 
mean recorded for each patient sample, statistical analysis was performed using a students 608 
unpaired t test, ***:p<0.001. (F-H) 20% of macrophages in peritoneal lesions are immuno-609 
positive for ERα, 100% are immuno-positive for ERβ. (F) CD68+ ERα+ cells were counted 610 
in each FOV (see above) and expressed as a proportion of CD68+ cells, statistical analysis 611 
was performed using a one-way ANOVA and Newman Keuls post-test. ***:p<0.001. (G) 612 
ERα immunolocalisation in endometriosis lesions (CD68; red, ERα; green). Inset shows 613 
enlarged area with an ERα+ macrophage (white arrow) adjacent to an ERα- macrophage 614 
(yellow arrow). (H) Macrophages in peritoneal lesions are immuno-positive for ERβ (green). 615 
Scale bars = 50µM.  (I) Significantly higher numbers of GFP+ macrophages were detected in 616 
peritoneal endometriosis lesions (n=8) compared to the healthy peritoneum (n=6). GFP+ cells 617 
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were counted in 4 randomly selected fields of view (FOV) associated with glandular and 618 
stromal tissue in lesions and the mean recorded for each sample, statistical analysis was 619 
performed using a students unpaired t test, ***:p<0.001. (J-L) 25% of macrophages in mouse 620 
peritoneal lesions are immuno-positive for ERα, 100% are immuno-positive for ERβ. (J) 621 
GFP+ ERα+ cells were counted in each FOV (see above) and expressed as a proportion of 622 
GFP+ cells, statistical analysis was performed using a one-way ANOVA and Newman Keuls 623 
post-test. ***:p<0.001. (K) ERα immunolocalisation in endometriosis lesions (GFP; red, 624 
ERα; green). (L) Macrophages in mouse peritoneal lesions are immuno-positive for ERβ 625 
(green). Scale bars = 50µM. (M-O) Peripheral blood monocytes were isolated and 626 
differentiated into macrophages in the presence of CSF-1. (M) Phenotype of cultured cells 627 
was verified using immunocytochemistry for CD68 (red) and expression of (N) ERα and (O) 628 
ERβ1confirmed (green). Scale bar = 50µM.  629 
Fig.2. Nerve fibres recruit macrophages in an estradiol-dependent manner via Ccl-2. 630 
(A) DRGs were stimulated for 24h with vehicle control (DMSO), E2 (10-8M) or E2 plus the 631 
anti-estrogen ICI (10-7M). Conditioned media (CM) was retained for use in the macrophage 632 
migration assay; macrophages (M(CSF-1); 5 X 10-4M cells per well) were placed in one 633 
chamber of the migration slide, DRG CM in the other. (B) M(CSF-1) migrated furthest 634 
towards CM from DRG exposed to E2 (p<0.01). Migration score was based on % cells 635 
mobilised and distance migrated. Mac media: unconditioned macrophage media (-ve control). 636 
Macrophages; n=4 patients, embryonic rat DRGs; n = 4 pregnant dams. (C-E) Estradiol up-637 
regulates mRNA concentrations of Csf-1 and chemokines in DRGs. The concentration of 638 
mRNAs encoding the macrophage growth factor Csf-1 and chemokines (Ccl-2 and Ccl-3) 639 
was analysed using QPCR in DRG exposed to DMSO, E2, or E2 plus ICI for 24h; (C) 640 
colony-stimulating factor (Csf-1), (D) chemokine (C-C motif) ligand 2 (Ccl-2) / monocyte 641 
chemotactic protein 1 (Mcp-1) and (E) chemokine (C-C motif) ligand (Ccl-3) / macrophage 642 
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inflammatory protein-1α (Mip-1α), n =5 cultures. RQ: Relative quantification. (F) The 643 
macrophage migration assay was performed as in (B), with the addition of anti-CCL-2 644 
(0.5μg/ml) or anti-CCL-3 (0.45μg/ml) antibodies to CM from DRGs exposed to DMSO or 645 
E2. Anti-CCL-2 abolished E2 induced chemotactic properties of DRG CM, whereas anti-646 
CCL-3 only attenuated E2 induced chemotactic properties of DRG CM. Statistical analysis 647 
was performed using a one-way ANOVA and Newman Keuls post-test. *:p<0.05, **:p<0.01, 648 
***:p<0.0001. 649 
Fig.3. M(CSF-1+E2) exhibit neurotrophic properties via BDNF and NT-3. (A) M(CSF-1) 650 
were exposed to DMSO, E2 or E2 plus ICI, the conditioned media (CM) retained and used to 651 
incubate single whole DRG immediately dissected from embryonic rats. (B-D) CM from 652 
M(CSF-1+E2) enhanced neurite outgrowth compared to CM from M(CSF-1+DMSO). (B-C) 653 
Immunocytochemistry performed on DRG using anti-Neurofilament (red) and nuclei 654 
counterstained with DAPI (blue). Scale bar = 500µM. (B) DRG grown in CM from M(CSF-655 
1+DMSO) and (C) CM from M(CSF1+E2). (D) Neurite outgrowth was quantified; the score 656 
was based on the % coverage of DRG and average length of neurites.  DRG media: 657 
unconditioned DRG media (NGF present; +ve control), Mac media: unconditioned 658 
macrophage growth media (-ve control). (E-F) The concentration of mRNAs encoding 659 
neurotrophins was analysed using QPCR in M(CSF-1) stimulated with DMSO, E2 or E2 plus 660 
ICI for 24h; (E) brain derived neurotrophic factor (BDNF) and (F) neurotrophin-3 (NT-3), 661 
n=5 volunteers. RQ: Relative quantification. (G-H) The neurotrophic properties of M(CSF-662 
1+E2) are BDNF and NT-3 dependent. Whole single DRG were cultured for 24h in CM from 663 
M(CSF-1+DMSO) or M(CSF-1+E2) for 24h, or CM from M(CSF1+E2) in the presence of an 664 
anti-BDNF (0.4µg/ml) or anti-NT-3 (0.2 µg/ml) antibody. (G) Immunocytochemistry 665 
performed on DRG using anti-Neurofilament. Scale bar = 500µM. (F) Quantification of 666 
neurite outgrowth in DRG incubated with CM from M(CSF-1+DMSO), M(CSF-1+E2) or 667 
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M(CSF-1+E2) in combination with anti-BDNF or anti-NT-3. DRG media; unconditioned 668 
DRG growth media, Mac media; unconditioned macrophage growth media. Statistical 669 
analysis was performed using a one-way ANOVA and Newman Keuls post-test. **:p<0.01, 670 
***:p<0.001. 671 
Fig.4. Macrophage infiltration of lesions is estradiol-dependent in a mouse model 672 
endometriosis. (A) Exposure of endometriosis mice to estradiol (E2; n=6) increased the 673 
number of macrophages present in endometriosis lesions compared to lesions from mice that 674 
had estradiol support withdrawn 7 days earlier (Control; n=4). The number of macrophages 675 
per lesions were counted and normalised to lesion area. (B-C) Images show representative 676 
fields of view from control mice (B) or mice exposed to E2 (C). Immunofluorescence was 677 
carried out using an anti-GFP antibody (green) and nuclei are stained blue with DAPI. Scale 678 
bar = 50µM. (D) QPCR analysis revealed Ccl-3 mRNA concentrations were elevated in 679 
lesions recovered from a mouse model of endometriosis. mRNA concentrations were 680 
measured in the uterus and peritoneum of naïve mice (NU and NP; n=6) and the peritoneum 681 
(EP) and lesions (EL) of mice with endometriosis (n=8). Statistical analysis was performed 682 
using a Students unpaired t-test or a one-way ANOVA and Newman Keuls post-test. 683 
*:p<0.05, **:p<0.01. 684 
Fig.5. Csf-1, Nt-3 and TrkB mRNA concentrations are elevated in endometriosis lesions 685 
and estradiol-regulated in a mouse model of endometriosis.  (A-C) Csf-1, Nt-3 and TrkB 686 
were elevated in lesions recovered from a mouse model of endometriosis. mRNA 687 
concentrations of Csf-1 (A), Nt-3 (B) and TrkB (C) were measured in the uterus and 688 
peritoneum of naïve mice (NU and NP; n=6) and the peritoneum (EP) and lesions (EL) of 689 
mice with endometriosis (n=8). (D-F) Csf-1, Nt-3, TrkB are regulated by estradiol in mouse 690 
endometriosis lesions. In a separate experiment mice were separated into groups that 691 
continued exposure to E2 (E2; n=6) or had estradiol treatment withdrawn (control; n=5) for 692 
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an additional 7 days. Peritoneal (P) and lesion (EL) biopsies were included in the analysis. 693 
Peritoneum from naïve mice (naïve P; n=6) was also included. mRNA concentrations of Csf-694 
1 (D), Nt-3 (E) and TrkB (F) were elevated in lesions from mice exposed to E2 compared to 695 
control mice. RQ; Relative quantification. Statistical analysis was performed using a one-way 696 
ANOVA and a Newman keuls post-test. *:p<0.05, **:p<0.01, ***:p<0.001. 697 
Fig.6. Estradiol enhances the interactions between macrophages and nerve fibres in 698 
endometriosis. Schematic representation of macrophage-nerve interactions in endometriosis. 699 
Nerve fibres increase the production of CSF-1 and CCL-2 in response to estradiol which 700 
enhances macrophage migration. Estradiol also acts on macrophages to increase production 701 
of BDNF and NT-3 resulting in increased neurogenesis. 702 
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Table 1: Primers sequences 714 
 715 
Gene Species Forward Reverse 
Csf-1 Rat 5’CAAGGACTATAAGGAACAGAACGAG3’ 5’GAAATTCTTGATTTTCTCCAGCA3’ 
Ccl-2 Rat 5’AGCATCCACGTGCTGTCTC3’ 5’GATCATCTTGCCAGTGAATGAG3’ 
Ccl-3 Rat 5’GCGCTCTGGAACGAAGTCT3’ 5’GAATTTGCCGTCCATAGGAG3’ 
Csf-1 Mouse 5’GGGGGCCTCCTGTTCTAC3’ 5’CCCACAGAAGAATCCAATGTC3’ 
Ccl-2 Mouse 5’CATCCACGTGTTGGCTCA3’ 5’GATCATCTTGCTGGTGAATGAGT3’ 
Ccl-3 Mouse 5’TGCCCTTGCTGTTCTTCTCT3’ 5’GTGGAATCTTCCGGCTGTAG3’ 
BDNF Human 5’GTAACGGCGGCAGACAAA3’ 5’GACCTTTTCAAGGACTGTGACC3’ 
NT-3 Human 5’AAAAACGGTTGCAGGGGTAT3’ 5’GGTTTGGGATGTTTTGCACT3’ 
Nt-3 Mouse 5’GGTGGTACCCTCTCCTCACTC3’ 5’GAAGAGCCCCTGTCATTCTG3’ 
TrkB Mouse 5’TTCTGCCTGCTGGTGATGT3’ 5’TCCAGTGGGATCTTATGAAACA3’ 
 716 
 717 
 718 
 719 
 720 
 721 
 722 
 723 
 724 
 725 
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Table 2: Antibodies used in immunofluorescence 726 
 727 
 728 
 729 
 730 
Antibody 
 
Raised 
in 
Tissue Dilution 
ERβ1 (Serotec # MCA1974S) Mouse Human  1:500 
ERβ (Santa Cruz # SC-8974) Rabbit Mouse 1:500 
ERα (Vector) Mouse Human and 
Mouse 
1:500 
PGP9.5 (Dako) Rabbit Human and 
Mouse 
1:1000 and 
1:3500 
CD68 (Clone KPI; Dako) Mouse Human 1:1200 
GFP (Invitrogen Molecular Probes 
#A11122) 
Rabbit Mouse 1:1500 
